The global spine biologics market is anticipated to grow through 2023, according to a Transparency Market Research report.
Here are five observations:
1. The growing popularity of biologics among surgeons and the minimally invasiveness of the procedure will boost the market.
2. The costliness of the biologics process will prove detrimental to market growth.
3. North America leads the space, with Europe coming in second.
4. The Asia-Pacific market will likely significantly grow, owing to an increasing population and improving medical technologies, among other factors.
5. Dominant market players include Alphatec Spine, DePuy Spine, Medtronic, Stryker, Smith & Nephew, Orthovita, Zimmer Biomet, K2M, NuVasive, Lattice Biologics, Arthrex, DMP Spine, Orthofix, RTI Surgical, Wright Medical Technology, Cesca Therapeutics and Precision Spine.